Structured Summary
Abstract
A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
9 entry terms
- CD20 Antibody, Rituximab
- Rituximab CD20 Antibody
- GP2013
- IDEC-C2B8
- IDEC-C2B8 Antibody
- Mabthera
- Rituxan
- IDEC C2B8
- IDEC C2B8 Antibody
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (1995)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Rituximab. Medical Subject Headings (MeSH). 2026. Unique ID D000069283. http://id.nlm.nih.gov/mesh/2026/D000069283
- Rituximab. In: Wikipedia. https://en.wikipedia.org/wiki/Rituximab
- Rituximab. In: Wikidata. https://www.wikidata.org/wiki/Q412323